Who owns PETROS PHARMACEUTICALS INC?
- Ticker: PTPI
- CUSIP Number: 71678j209
Tip: Access positions for across all investors
Analyze quarterly positions in Petros Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Petros Pharmaceuticals stock
Who bought or sold PETROS PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Two Sigma Securities | 54k | $25k | 100% | Jun 2024 |
|
Geode Capital Management | 38k | $13k | 24% | Sep 2024 |
|
Vanguard Group | 32k | $15k | 0% | Jun 2024 |
|
BlackRock | 17k | $7.6k | 0% | Jun 2024 |
|
BlackRock | 16k | $5.8k | 100% | Sep 2024 |
|
Tower Research Capital | 3.3k | $1.5k | -4% | Jun 2024 |
|
Emfo | 1.0k | $458.000000 | 0% | Jun 2024 |
|
National Bank Of Canada /fi/ | 313.00 | $111.991400 | 0% | Sep 2024 |
|
Advisor Group Holdings | 200.00 | $72.000000 | 1329% | Sep 2024 |
|
Group One Trading | 79.00 | $27.997600 | 0% | Sep 2024 |
|
Bank of America Corporation | 72.00 | $25.999200 | 33% | Sep 2024 |
|
Morgan Stanley | 19.00 | $8.941400 | -96% | Jun 2024 |
|
Who sold out of Petros Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Virtu Financial | Jun 2024 | 70k | $32k |